| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/06/2010 | US20100112077 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 05/06/2010 | US20100112076 Gellan-Gum Nanoparticles and Methods of Making and Using the Same |
| 05/06/2010 | US20100112075 Compositions of microparticles and granules for oral controlled release of substances for veterinary use |
| 05/06/2010 | US20100112073 Water-Soluble Nanoparticles Containing Water-Insoluble Compounds |
| 05/06/2010 | US20100112072 Controllable Virus/Protein Assemblies and Methods of Making the Same |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100112070 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 05/06/2010 | US20100112069 Flowable Carrier Matrix |
| 05/06/2010 | US20100112068 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100112067 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100112066 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 05/06/2010 | US20100112065 Therapeutic ultrasound gel |
| 05/06/2010 | US20100112064 Transdermal therapeutic system comprising ion pair microreservoirs |
| 05/06/2010 | US20100112063 Method for preparing a hydrogel adhesive having extended gelation time and decreased degradation time |
| 05/06/2010 | US20100112061 Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis |
| 05/06/2010 | US20100112059 Methods, Systems and Devices for Administration of Chlorine Dioxide |
| 05/06/2010 | US20100112057 Multifunctional and biologically active matrices from multicomponent polymeric solutions |
| 05/06/2010 | US20100112056 Immediate release dosage forms of sodium oxybate |
| 05/06/2010 | US20100112055 Microporous film and preparation and use thereof |
| 05/06/2010 | US20100112054 Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates |
| 05/06/2010 | US20100112053 Gastric retention-type sustained-release levodopa preparation |
| 05/06/2010 | US20100112052 Osmotic tablet with a compressed outer coating |
| 05/06/2010 | US20100112051 Tianeptine sulfate salt forms and methods of making and using the same |
| 05/06/2010 | US20100112050 Dosage Form For Insertion Into The Mouth |
| 05/06/2010 | US20100112049 improved bioavailabilty; micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant |
| 05/06/2010 | US20100112048 Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid |
| 05/06/2010 | US20100112047 Omega 3 fatty acid formulations |
| 05/06/2010 | US20100112046 Formulations of suberoylanilide hydroxamic acid and methods for producing same |
| 05/06/2010 | US20100112045 Surface-treated modafinil particles |
| 05/06/2010 | US20100112044 Method and apparatus for encapsulating pharmaceutical and nutriceutical bioactives for intestinal delivery |
| 05/06/2010 | US20100112043 Transpulmonary liposome for controlling drug arrival |
| 05/06/2010 | US20100112042 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 05/06/2010 | US20100112041 Endoxifen Compositions And Methods |
| 05/06/2010 | US20100112040 Preparation of Heavy Metal-Containing Nano-Liposomes and their Uses in Medical Therapy |
| 05/06/2010 | US20100112039 Lornafarnib in combination with a taxane selected from paclitaxel and docetaxel, and also carboplatin, cisplatin or oxaliplatin |
| 05/06/2010 | US20100112038 Methods of treating neurological conditions with hematopoeitic growth factors |
| 05/06/2010 | US20100112036 Cyanoacrylate-based liquid microbial sealant drape |
| 05/06/2010 | US20100112035 Multiple component food product useful for delivering glucosamine and/or n-acetyl-d-glucosamine |
| 05/06/2010 | US20100112032 Bone/Polyurethane Composites and Methods Thereof |
| 05/06/2010 | US20100112028 Composite material for use as protein carrier |
| 05/06/2010 | US20100112027 Penis Enlargement |
| 05/06/2010 | US20100112026 Surfaces, methods and devices employing cell rolling |
| 05/06/2010 | US20100112021 Sustained-release composition |
| 05/06/2010 | US20100112018 Microcapsule, structure having a microcapsule, article having a microcapsule, and method of preparing microcapsules |
| 05/06/2010 | US20100112016 Ophthalmic oil-in-water emulsions containing prostaglandins |
| 05/06/2010 | US20100112015 Orally administered agent and an orally administered agent/supporting substrate complex |
| 05/06/2010 | US20100112014 Novel hydrogel compositions and methods of using |
| 05/06/2010 | US20100112003 Bifidobacterium in the treatment of inflammatory disease |
| 05/06/2010 | US20100111879 Saccharide foamable compositions |
| 05/06/2010 | US20100111877 Foam disinfectant |
| 05/06/2010 | US20100111876 Use of metal nanoparticles in the diagnosis of alzheimer's disease |
| 05/06/2010 | US20100111857 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111855 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111854 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111850 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111849 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111848 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111847 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111846 Compositions and methods for delivery of frozen particle adhesives |
| 05/06/2010 | US20100111845 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111844 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111843 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111842 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111841 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
| 05/06/2010 | US20100111836 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111833 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111832 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111831 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111830 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111829 Flowable composition that hardens on delivery to a target tissue site beneath the skin |
| 05/06/2010 | CA2742650A1 Nanoparticles of beta-lactam derivatives |
| 05/06/2010 | CA2742227A1 Fatty acids for use as a medicament |
| 05/06/2010 | CA2742181A1 Statin nanoparticles |
| 05/06/2010 | CA2741701A1 Osmotic tablet with a compressed outer coating |
| 05/06/2010 | CA2740509A1 Formulation for treatment of vaginal dryness |
| 05/06/2010 | CA2738970A1 Topical composition comprising a combination of at least two penetration enhancing agents |
| 05/05/2010 | EP2181721A2 Product for caring for inflammation, pressure sores and/or ulcers in the mouth area and the use of such a product |
| 05/05/2010 | EP2181716A1 Process for producing coated preparation |
| 05/05/2010 | EP2181706A2 Florfenicol esters for treating bacterial infections |
| 05/05/2010 | EP2181705A1 Sustained-release formulation of gliclazide |
| 05/05/2010 | EP2181704A2 Drug delivery from rapid gelling polymer composition |
| 05/05/2010 | EP2181121A2 Chimeric antigens |
| 05/05/2010 | EP2180887A2 Pharmaceutical preparations containing highly volatile silicones |
| 05/05/2010 | EP2180885A2 Pharmaceutical product comprising yeast |
| 05/05/2010 | EP2180884A1 Central administration of stable formulations of therapeutic agents for cns conditions |
| 05/05/2010 | EP2180883A1 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 05/05/2010 | EP2180882A2 Solid matrix pharmaceutical preparation |
| 05/05/2010 | EP2180881A2 Vesicles comprising a transmembrane transport trigger system |
| 05/05/2010 | EP2180880A2 Micelle encapsulation of therapeutic agents |
| 05/05/2010 | EP2180844A2 Sublingual fentanyl spray |
| 05/05/2010 | EP1850889B1 Depolymerized polysaccharide-based hydrogel adhesive and methods of use thereof |
| 05/05/2010 | EP1781251B1 Polyvinyl alcohol gels, especially in situ gelling gels |
| 05/05/2010 | EP1734987B1 Interferon-beta for anti-virus therapy for respiratory diseases |
| 05/05/2010 | EP1713468B1 Anthelmintic composition |
| 05/05/2010 | EP1590077B1 Microencapsulation systems and applications of same |
| 05/05/2010 | EP1485081B1 Ibuprofen solution for hard shell capsules |
| 05/05/2010 | EP1274414B1 Nasal administration of metoclopramide for the treatment of gastroparesis |
| 05/05/2010 | EP1267894B1 Viscoelastics for use in middle ear surgery |
| 05/05/2010 | CN201445698U Breathing-assisted nasal stripe |